atopic dermatitis treatments

Targeted treatments for atopic dermatitisEmerging treatments are expected to help fill the need for safer and more effective therapies for atopic dermatitis (AD). Both systemic and topical treatments are needed to provide full and complete treatment for patients with AD. Targeting the specific axis or axes that control AD may contribute to developing personalized approaches to treatment
New hope for eczemaThe US Food and Drug Administration (FDA) has announced its approval of a new, corticoid-sparing ointment to treat mild to moderate atopic dermatitis in pediatric patients aged 2 years and older.
October clinical considerations for NPs, PAsThis month, we examine how to recognize Zika virus, a new therapeutic option for AD, and the concept of field cancerization in treating actinic keratosis.
Drug pipeline developments: Alopecia areata and atopic dermatitisPromising treatments are coming for alopecia areata and atopic dermatitis, but they will come at a high cost.
Restoring the balance: skin microbiome in atopic dermatitisResearch has demonstrated that staph aureus is in increased supply on the skin of atopic dermatitis patients coupled with less overall diversity in the number of bacteria on their skin, suggesting therapies that achieve balance in the skin microbiome could help to manage atopic dermatitis.
Investigative eczema drug shows positive phase 2 resultsUK-based Ziarco Pharma Ltd. recently announced positive phase 2a results for ZPL-389, a once daily oral histamine H4 receptor antagonist, for the treatment of moderate to severe atopic dermatitis.
What we know today about applying oils to newborn skinThe use of olive or sunflower oil on newborn babies’ skin damages the skin barrier, researchers from the University of Manchester recently reported. This latest study adds to the conflicting information around caring for newborn skin and how to manage conditions like atopic dermatitis. Learn more
Trending therapies for atopic dermatitisBeyond the current approaches, recent phase 3 data has become available on a new topical while another injectable drug is under development, and both appear very promising.
Managing severe pediatric atopic dermatitisOlder non-specific immunomodulatory drugs and off-label use of several biologic agents offer treatment options for children with severe atopic dermatitis (AD). However, the future should bring therapies specifically developed for treatment of AD investigated in children.
Rheumatoid arthritis drug may benefit atopic dermatitis patientsPatients with moderate to severe atopic dermatitis (AD)—or eczema—may be successfully treated using a rheumatoid arthritis (RA) drug recently shown to reverse 2 other skin conditions, vitiligo and alopecia areata, according to findings published early online in the Journal of the American Academy of Dermatology.